Incyte, Syndax announce FDA approval for Niktimvo vial sizes
Incyte (INCY) and Syndax (SNDX) announced that the FDA has approved Niktimvo in 9 mg and 22 mg vial sizes. The companies expect product to be ...
MassDevice17h
BD increases U.S. syringe, IV catheter manufacturing
BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...
Denver Council Approves Needle Exchanges Next to Schools, Day Care Centers
City councilwoman Amanda Sawyer, who opposed the bill, said a needle exchange in her district has been a ‘terrible neighbor.’ ...
Becton Dickinson to invest $30M in IV production capacity
Becton Dickinson plans to invest more than $30M in 2025 to expand its manufacturing capacity for IV lines at its Utah plant.
Becton Dickinson Ramps Ups Medical Device Production for FY25
Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...